CUA Educational Content

Collaborative Practice in Prostate Cancer: How is this actually done?


Session #3 of the Prostate Cancer and Cardiovascular Disease program series
In partnership with IC-OS and EAU

sponsors


DESCRIPTION:

  • CV decision-making in advanced PC
  • Discuss factors that influence recommendations for CABG, valve surgery, transcatheter valve intervention in patients with metastatic PC
  • Optimal cardioprotective therapy for high-risk patients
  • Should ADT or androgen receptor blockers be withheld (if ever)?
  • Acute MI, HTN out of control, etc.
  • Any CV conditions that preclude this treatment
  • Considerations of complex decisions around antithrombotic therapies

 

image

 

This program has received financial support from Ferring in the form of an educational grant.

The Canadian Urological Association (CUA) does not provide professional medical advice, diagnosis or treatment and cannot respond to requests for direct feedback, specific patient information or physician referrals. You should first always seek the advice of your urologist, physician and other qualified health provider with any questions regarding your medical condition. The contents of the CUA Website such as text, graphics, images, and other content are for informational purposes only. The content/information is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on the CUA website.

For comments or information, email Corporate.office@cua.org

Privacy Policy